Today: 9 April 2026
Browse Category

Nasdaq-100 13 December 2025 - 18 January 2026

AstraZeneca stock: Nasdaq-100 exit date nears as index flows and JPM conference loom

AstraZeneca stock: Nasdaq-100 exit date nears as index flows and JPM conference loom

AstraZeneca will be removed from the Nasdaq-100 on Jan. 20, replaced by Walmart, Nasdaq said Friday. AstraZeneca shares rose 0.28% in London and 0.68% in New York after the announcement. Index funds are expected to adjust holdings near the effective date, potentially increasing trading volume. AstraZeneca management is set to speak at the JPMorgan Healthcare Conference starting Monday.
Invesco QQQ (QQQ) Sees New Institutional Position Shifts on Dec. 26 as Nasdaq-100 ETF Trading Resumes After Christmas

Invesco QQQ (QQQ) Sees New Institutional Position Shifts on Dec. 26 as Nasdaq-100 ETF Trading Resumes After Christmas

Park Capital Management raised its QQQ stake by 38.4% in Q3, while Cwm LLC and Capital Advisors Wealth Management also increased holdings, SEC filings show. TrueWealth Advisors cut its QQQ position by nearly 25%. Founders Financial Securities and HWG Holdings reported double-digit percentage increases in QQQ earlier this week. QQQ remains a major holding for several firms.
26 December 2025
Western Digital (WDC) Stock After Hours on Dec. 22, 2025: Nasdaq-100 Debut, Today’s Headlines, Analyst Forecasts, and What to Watch Before Tuesday’s Open

Western Digital (WDC) Stock After Hours on Dec. 22, 2025: Nasdaq-100 Debut, Today’s Headlines, Analyst Forecasts, and What to Watch Before Tuesday’s Open

Western Digital closed down 2.39% at $176.76 Monday, its first session as a Nasdaq-100 member. Shares traded near $176.58 after hours. The index addition took effect ahead of the market open, triggering rebalancing flows and heightened trading volume. WDC remains just below its 52-week high of $188.77.
23 December 2025
Alnylam Pharmaceuticals (ALNY) Stock After Hours: Nasdaq-100 debut, fresh catalysts, and what to watch before Tuesday’s open (Dec. 23)

Alnylam Pharmaceuticals (ALNY) Stock After Hours: Nasdaq-100 debut, fresh catalysts, and what to watch before Tuesday’s open (Dec. 23)

Alnylam Pharmaceuticals closed up 1.87% at $407.73 Monday, its first session as a Nasdaq-100 constituent. The stock slipped 0.12% after hours. Index inclusion drove trading volume to about 1.05 million shares. Alnylam recently announced a $250 million expansion of its Massachusetts manufacturing site.
Insmed (INSM) Stock After Hours Today (Dec. 22, 2025): Closing Price, Nasdaq-100 Effect, Fresh Forecasts, and What to Watch Before Tuesday’s Open

Insmed (INSM) Stock After Hours Today (Dec. 22, 2025): Closing Price, Nasdaq-100 Effect, Fresh Forecasts, and What to Watch Before Tuesday’s Open

Insmed shares closed Monday at $175.76, up 0.53%, then traded between $175.76 and $178.05 after hours. The stock joined the Nasdaq-100 effective Dec. 22, prompting index-related activity. No new company announcements appeared after the bell. Investors continued to weigh last week’s brensocatib CRSsNP trial failure.
23 December 2025
Western Digital (WDC) Stock After Hours Today (Dec. 22, 2025): Post-Close Update, Nasdaq-100 Impact, and What to Watch Before Tuesday’s Open

Western Digital (WDC) Stock After Hours Today (Dec. 22, 2025): Post-Close Update, Nasdaq-100 Impact, and What to Watch Before Tuesday’s Open

Western Digital closed Monday at $176.76, down 2.39%, then edged up 0.21% to $177.13 in after-hours trading. The stock swung between $171.91 and $187.24 on heavy volume as it debuted in the Nasdaq-100 index. Broader U.S. markets rose on light pre-holiday trading. Index rebalancing and thin liquidity drove volatility.
23 December 2025
Seagate Technology Holdings plc (STX) Stock After Hours on Dec. 22, 2025: Nasdaq‑100 Inclusion, Dividend Deadline, and What to Watch Before the Dec. 23 Market Open

Seagate Technology Holdings plc (STX) Stock After Hours on Dec. 22, 2025: Nasdaq‑100 Inclusion, Dividend Deadline, and What to Watch Before the Dec. 23 Market Open

Seagate Technology shares fell 4.55% to $282.85 Monday, reversing sharply despite joining the Nasdaq‑100 that day. The stock swung between $279.50 and $302.40 on heavy volume, while other data-storage names also declined. After hours, STX edged higher in thin trading. Investors are watching index reconstitution effects and an imminent dividend deadline.
Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals joined the Nasdaq-100 Index on Dec. 22, 2025, as the annual reconstitution took effect before the market opened. Shares traded near $405.60, up 1.3% from the prior close. The company recently announced a $250 million U.S. manufacturing expansion and reported strong adoption of its AMVUTTRA therapy for transthyretin amyloidosis.
Monolithic Power Systems (MPWR) Stock on Dec. 22, 2025: Nasdaq-100 Debut, Analyst Targets, Dividend, and Fresh Technical Signals

Monolithic Power Systems (MPWR) Stock on Dec. 22, 2025: Nasdaq-100 Debut, Analyst Targets, Dividend, and Fresh Technical Signals

Monolithic Power Systems joined the Nasdaq-100 Index before the market opened Monday, Dec. 22, 2025. Shares traded near $958.73, up 2.3% on the day, with a session range of $949.33 to $970.00. Analysts maintain a “Buy” consensus, with a 12-month average target of $1,196. The company declared a $1.56 quarterly dividend, payable Jan. 15, 2026.
Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals joins the Nasdaq-100 before the U.S. market opens Dec. 22, prompting index-tracking funds to adjust positions. Shares last closed at $400.23. The company’s drug Amvuttra recently secured routine NHS use in England and Health Canada approval for ATTR cardiomyopathy. Alnylam also announced a $250 million manufacturing expansion and new FDA recognition for its technology platform.
Insmed Incorporated (NASDAQ: INSM) Stock Week Ahead: Nasdaq-100 Addition Meets Brensocatib Setback—News, Forecasts, and What to Watch (Dec. 22–26, 2025)

Insmed Incorporated (NASDAQ: INSM) Stock Week Ahead: Nasdaq-100 Addition Meets Brensocatib Setback—News, Forecasts, and What to Watch (Dec. 22–26, 2025)

Insmed will join the Nasdaq-100 before markets open Monday, December 22, 2025. Shares fell 11% last week after the company halted development of brensocatib in chronic rhinosinusitis without nasal polyps following a failed Phase 2b trial. The stock last traded near $174.84. Holiday trading may affect liquidity and volatility.
21 December 2025
Western Digital (WDC) Stock Week Ahead (Dec. 22–26, 2025): Nasdaq-100 Inclusion, Analyst Targets, and What to Watch

Western Digital (WDC) Stock Week Ahead (Dec. 22–26, 2025): Nasdaq-100 Inclusion, Analyst Targets, and What to Watch

Western Digital joins the Nasdaq-100 before markets open Monday, Dec. 22, 2025, prompting expected buying by passive index funds. Shares last traded near $181, close to a 52-week high. U.S. markets will close early Dec. 24 and remain shut Dec. 25, raising the risk of sharp price swings on thin holiday volume. The company’s recent split from Sandisk has refocused its business on storage infrastructure.
21 December 2025
ProShares UltraPro QQQ (TQQQ) Stock: Latest News, Price Action, Nasdaq-100 Rebalance and 2026 Outlook (December 14, 2025)

ProShares UltraPro QQQ (TQQQ) Stock: Latest News, Price Action, Nasdaq-100 Rebalance and 2026 Outlook (December 14, 2025)

ProShares UltraPro QQQ (TQQQ) closed at $52.82 on Friday, down 5.86% with 138 million shares traded, after a sharp tech selloff fueled by renewed concerns over an AI bubble and inflation. The Nasdaq-100 annual reconstitution takes effect before the open on Dec. 22, forcing index-tracking funds to adjust positions. U.S. markets are closed Sunday. Regulators warn leveraged ETFs like TQQQ can diverge from expected returns in volatile markets.
14 December 2025
Seagate Technology (STX) Stock: Weekly Recap and Week-Ahead Outlook as Nasdaq-100 Inclusion Looms (Updated Dec. 12, 2025)

Seagate Technology (STX) Stock: Weekly Recap and Week-Ahead Outlook as Nasdaq-100 Inclusion Looms (Updated Dec. 12, 2025)

Seagate Technology shares fell 6.56% Friday to $287.64 after hitting a 52-week high of $308.93 Thursday. The drop came on heavy volume as tech stocks slid amid renewed “AI bubble” concerns. After the close, Nasdaq announced Seagate will join the Nasdaq-100, effective Dec. 22. Index inclusion is expected to drive trading volume and volatility in the coming week.
13 December 2025

Stock Market Today

  • Thomson Reuters (TRI) Upgraded to Buy on Rising Earnings Estimates
    April 9, 2026, 2:13 PM EDT. Thomson Reuters (TRI) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates, a key factor influencing stock price movements. The Zacks rating, based solely on changes in earnings potential, signals an improved business outlook. This upgrade reflects growing confidence among institutional investors, who adjust share valuations based on earnings revisions, leading to potential stock price gains. The company is expected to earn $4.40 per share for the fiscal year ending December 2026, in line with last year. This upgrade highlights the importance of tracking earnings estimate revisions as a strategy for investment decisions in the near term.

Latest article

Gold Price Today: Bullion Jumps as Dollar Slips and Fragile Iran Truce Keeps CPI in Focus

Gold Price Today: Bullion Jumps as Dollar Slips and Fragile Iran Truce Keeps CPI in Focus

9 April 2026
Spot gold rose 1.6% to $4,789.67 an ounce by 1:30 p.m. ET Thursday as the U.S. dollar weakened and Treasury yields slipped. U.S. gold futures settled 0.9% higher at $4,818.00. Traders watched a fragile ceasefire between Washington and Tehran and awaited Friday’s U.S. inflation data. March saw gold’s steepest monthly drop since 2008, according to China’s central bank.
Dow Jones Today: Industrial Average Climbs as Oil Retreats, but Inflation Risk Keeps Wall Street Wary

Dow Jones Today: Industrial Average Climbs as Oil Retreats, but Inflation Risk Keeps Wall Street Wary

9 April 2026
The Dow Jones rose 247.66 points to 48,155.97 by midday Thursday, following a surge linked to signs of Middle East de-escalation and Israeli plans for peace talks with Lebanon. Oil prices fell over $4 a barrel after Netanyahu’s remarks, but remain 40% above pre-conflict levels. Amazon climbed 4.3% on strong AI revenue. Traders now see only a 30% chance of a Fed rate cut by year-end, down from 56%.
US Stock Market Today: Wall Street Rises Again, but Oil and Fed Fears Keep the Rally on Edge

US Stock Market Today: Wall Street Rises Again, but Oil and Fed Fears Keep the Rally on Edge

9 April 2026
The Dow rose 337 points, or 0.7%, by 1 p.m. Thursday as oil prices retreated after Israel announced direct talks with Lebanon and hopes for a U.S.-Iran ceasefire steadied markets. Amazon shares climbed on news its AWS AI services topped $15 billion in annualized revenue. The Fed signaled possible rate hikes if inflation persists. Oil shipments through the Strait of Hormuz remained sharply reduced.
Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

9 April 2026
Amazon shares rose 5% Thursday after CEO Andy Jassy revealed AWS’s AI services are generating over $15 billion annually and its chip business more than $20 billion. Jassy said much of AWS’s $200 billion in planned 2026 spending is backed by customer commitments, including a $100 billion OpenAI deal. He also highlighted deep job cuts and a push for smaller teams. Amazon now operates over 1 million robots and plans to launch its Leo satellite network in mid-2026.
Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

9 April 2026
Unilever said Thursday it will acquire U.S. greens-supplement brand Grüns for an undisclosed sum, with the deal expected to close later this year pending approvals. Grüns was valued at about $500 million in a 2025 Series B round, according to Reuters. The purchase follows Unilever’s recent agreement to combine its food business with McCormick.
Go toTop